Susmed (TSE:4263) 5-Year EBITDA Growth Rate

: 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

Susmed's EBITDA per Share for the three months ended in Dec. 2023 was 円3.17.

During the past 3 years, the average EBITDA Per Share Growth Rate was 36.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 4 years, the highest 3-Year average EBITDA Per Share Growth Rate of Susmed was 36.80% per year. The lowest was 36.80% per year. And the median was 36.80% per year.

Competitive Comparison

For the Health Information Services subindustry, Susmed's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Susmed 5-Year EBITDA Growth Rate Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Susmed's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Susmed's 5-Year EBITDA Growth Rate falls into.

Susmed 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Susmed (TSE:4263) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Susmed 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Susmed's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Susmed (TSE:4263) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Susmed Inc (TSE:4263) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-7-2, Honcho, Nihombashihoncho, Chuo-ku, Tokyo, JPN, 103-0023

Website

https://www.susmed.co.jp

Susmed Inc is engaged in the development of medical equipment and software systems Collection and distribution of medical information.

Susmed (TSE:4263) Headlines

No Headlines